Featured at the Medical Device Forum of 2026 Zhangjiang Pharma Valley Innovation Conference

The event will establish a city-wide pharmaceutical and medical device overseas consortium, link up the overseas service platforms in each district to form a "platform service team", and bring together key companies, industry experts and representatives of international organizations to jointly discuss the path of global development and fully demonstrate the innovative strength and overseas ecology of Shenzhen's pharmaceutical and medical device industry.

On March 21, 2025, the National Medical Products Administration officially approved the launch of the Weimai Medical ETcath® interventional surgery assistance system - this marks the birth of the world's first interventional surgery robot that realizes the "eye-hand-brain" trinity, and China has completed a historic leap from "following" to "leading" in the field of high-end medical equipment.

With the rapid development of the global medical device market, the clinical requirements and regulatory policies of medical devices in the EU and China, as two major global markets, have attracted much attention. In order to help medical device companies better understand the clinical data requirements of the EU and Chinese markets, AKRA TEAM and LINKS CRO jointly held a webinar focusing on the clinical requirements of medical devices in the EU and China, bringing you the most cutting-edge industry insights and practical guidelines.

For the first time, the online model was adopted to closely connect offices and cities across the country to celebrate this milestone together. The main venue was set up in the Nanjing office, which became a warm harbor for our online gathering.